Moat Stocks Remain Ahead in Volatile Market

This article was originally published on ETFTrends.com.

By Coulter Regal, CFA
Associate Product Manager

The Morningstar Wide Moat Focus Index outperformed the S&P 500 Index in 2022 as of the end of August despite recent stock market volatility, driven by sector allocations and stock selection.

August was a volatile month for stocks, as investors attempted to digest the renewed hawkish tone coming from the U.S. Federal Reserve (Fed). Fed Chair Jerome Powell addressed inflation challenges at the Jackson Hole conference with language reminiscent of former chair Paul Volcker. Powell iterated that higher rates for longer may be needed to bring inflation under control, despite greater recession risk. He even went as far as acknowledging that central bank policy may cause “some pain” to the U.S. economy in the near term. Major U.S. market indexes, which were initially up through the first half of August, crashed following these comments to end the month in negative territory.

The Morningstar® Wide Moat Focus IndexSM (the “Moat Index” or “Index”) remains ahead of the S&P 500 index by 4% in 2022 (-12.1% vs. -16.1%, respectively), as of 8/31/2022. This is despite lagging the S&P 500 in August (-4.8% vs. -4.1%, respectively). The Moat Index’s outperformance so far this year has been driven by a combination of positive sector allocation and strong stock selection, particularly within the Consumer Staples and Healthcare sectors. However, for the month of August, it was selection effect within technology that drove underperformance relative to the S&P 500.

Top 5 Moat Index Contributors in August

Company

Ticker

Average Weight (%)

Return Contribution (%)

Gilead Sciences Inc.

GILD

2.75

0.17

MercadoLibre Inc.

MELI

2.32

0.12

Compass Minerals International

CMP

0.94

0.08

Meta Platforms Inc.

META

2.15

0.05

Charles Schwab Corp.

SCHW

1.41

0.04

Bottom 5 Moat Index Contributors in August

Company

Ticker

Average Weight (%)

Return Contribution (%)

Teradyne Inc.

TER

2.52

-0.40

Salesforce Inc.

CRM

2.52

-0.38

Veeva Systems Inc.

VEEV

3.22

-0.35

The Western Union Co.

WU

2.69

-0.35

3M Co.

MMM

2.74

-0.34

Source: Morningstar. Past performance is no guarantee of future results. Index performance is not illustrative of fund performance. Not intended as a recommendation to buy or to sell any of the securities mentioned herein. For a complete list of holdings in the ETF, please visit www.vaneck.com.

Wide Moat Stock Highlights

Gilead Sciences Inc. (GILD)1

Gilead Sciences (GILD) is a drug manufacturer that develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Acquisitions over the last few years has helped broadened this focus to also include pulmonary and cardiovascular diseases and cancer. Morningstar attributes Gilead’s wide moat rating to their strong patent protection and expertise in infectious diseases and single-pill formulations. GILD was the top contributor to performance for the Moat Index in August following strong second-quarter earnings and increased sales guidance for the remainder of the year on strong HIV and oncology sales.